EP2510911A1 — Apparatus for intraocular injection
Assigned to Sanofi Aventis Deutschland GmbH · Expires 2012-10-17 · 14y expired
What this patent protects
An apparatus for intraocular injection comprising a body (101) adapted to accommodate an injection device, a displacement device (110) coupled to a distal end (102) of the body (101), and a sleeve (104) coupled to the body (101) and axially moveable relative to the body (101). Th…
USPTO Abstract
An apparatus for intraocular injection comprising a body (101) adapted to accommodate an injection device, a displacement device (110) coupled to a distal end (102) of the body (101), and a sleeve (104) coupled to the body (101) and axially moveable relative to the body (101). The displacement device (110) includes at least one rotatable member adapted to contact a superficial layer of an eye (50), and the sleeve (104) engages and causes rotation of the at least one rotatable member as the sleeve moves from a first axial position to a second axial position. Rotation of the at least one rotatable member displaces the superficial layer relative to an underlying layer of the eye (50).
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.